Abstract:Aerobic exercise is increasingly examined for its efficacy on preventing and treating Alzheimer's disease (AD) because it could potentially improve brain structure and function. However, its reported effects in AD have been controversial with limited studies, which are largely attributable to: wide variations and insufficient doses of prescribed aerobic exercise. The standard measures in drug trials, e.g., the AD Assessment Scale - cognition (ADAS-cog), have not been used in exercise studies. This study pilot tested how 6-month cycling affects ADAS-cog and other symptoms using a single-blinded, single-group, repeated-measures design in older adults with mild to moderate AD. The ADAS-cog, Disability in AD (DAD), and Neuropsychiatric Inventory (NPI-Q) were administered at baseline, 3 and 6 months. Of the 28 enrolled subjects (Table 1), 26 completed 3-month data collection and 22 completed 6-month data collection. Missing 6-month data were imputed for four participants as follows to prevent artificially improve the a) If the 3-month values were higher than baseline values (indicating outcome worsening), this increase was added to the 3-month values to estimate the missing 6-month values; and b) If the 3-month values were lower than baseline values (indicating outcome improvement), then the 3-month values were imputed as the 6-month values. Analyses were performed using mixed linear model in SAS and graphs were drawn using R project. Participants > age 65 years did not increase their ADAS-cog scores from baseline while those ≤ age 65 did (Table 2). This difference between age groups was highly significant (p = .004 for age-study-month interaction). Participants > age 65 maintained their baseline ADAS-cog score on average, with 95% confidence interval (-2.4 to 2.9) for the change (Table 2 and Figure 1). In addition, participants maintained DAD and NPI-Q severity scores over time (Table 2) with no age differences in changes. Caregiver distress significantly decreased almost 40% from baseline (p < .05). The stability of ADAS-cog is highly significant because older adults with mild to moderate AD receiving placebo in AD drug trials increased 2.4 - 3.9 points. Aerobic exercise maintained function and neuropsychiatric symptoms, while substantially reduced caregiver distress. 6-month change in ADAS-cog by participant's baseline age. Observed changes are shown by black filled circles; imputed changes are shown by gray filled circles. Correlation between age and 6m change in ADAS-cog was r = –.38 (p = .054).

Establishing Reference Cardiorespiratory Fitness Parameters in Alzheimer's Disease.

Cardiorespiratory Fitness Assessment for Exercise Research in Mild Cognitive Impairment Due to Alzheimer's Disease

AEROBIC FITNESS: A TARGET FOR INTERVENTION IN ALZHEIMER’S DISEASE

Exercise Dose and Aerobic Fitness Response in Alzheimer's Dementia: Findings from the FIT-AD Trial

Maintaining physical fitness and function in Alzheimer's disease: a pilot study.

Determination of Aerobic Capacity via Cycle Ergometer Exercise Testing in Alzheimer's Disease.

P2-350: prescribing aerobic exercise to older adults with alzheimer's disease

Inter-individual differences in the responses to aerobic exercise in Alzheimer's disease: Findings from the FIT-AD trial

Aerobic Fitness and Cognition Changes after Exercise Training in Alzheimer's Disease

Aerobic training for older men with Alzheimer's disease: individual examples of progression.

Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trial

Facilitating aerobic exercise training in older adults with Alzheimer's disease.

P4-171: aerobic exercise in alzheimer's disease: the fit-ad trial

O3‐12‐04: Cognitive Responses to Exercise in Alzheimer's Disease

The effects of aerobic exercise on cognitive function of Alzheimer's disease patients.

P2–329: How Aerobic Exercise Affects Cognition: A Pilot Study

A Comparison of Cardiopulmonary Exercise Testing and Field Walking Tests in Community-Dwelling Older Adults with Mild-to-Moderate Alzheimer’s Dementia

Correlating Heart Rate and Perceived Exertion During Aerobic Exercise in Alzheimer'S Disease

Aerobic Exercise, Training Dose, and Cardiorespiratory Fitness: Effects and Relationships with Resting Plasma Neurotrophic Factors in Alzheimer's Dementia

Aerobic Exercise, Training Dose, and Cardiorespiratory Fitness: Effects and Relationships with Resting Plasma Neurotrophic Factors in Alzheimer’s Dementia

Cognitive and Physical Factors Affecting Daily Function in Alzheimer's Disease: A Cross‐sectional Analysis